NeuralCipher Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
Effective Parkinson's disease (PD) management is hindered by the intermittent nature of clinical snapshots and the discomfort of rigid monitoring hardware. This review critically evaluates the synergy between flexible bioelectronics and artificial intelligence (AI) for continuous remote monitoring. Our analysis reveals that while material innovations have achieved milligram-level sensitivity, a significant 'translational gap' persists due to limited validation in real-world environments and small cohort sizes. We conclude that multimodal fusion architectures are essential for accurately mapping digital biomarkers to clinical gold standards such as MDS-UPDRS. By leveraging edge AI for privacy and closed-loop feedback for intervention, this integration facilitates the transition from reactive clinical visits to proactive, personalized digital home-care ecosystems.
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.